According to KEGG pathway enrichment analysis and literature, the molecular mechanism of puerarin in the therapy of EHF/COVID-19 may be related to HIF-1, TNF, IL-17, and Toll-like receptor signaling pathway. This evidence concerns the gene TNF and COVID-19.